Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.

Dimastromatteo J, Broisat A, Perret P, Ahmadi M, Boturyn D, Dumy P, Fagret D, Riou LM, Ghezzi C.

J Nucl Med. 2013 Aug;54(8):1442-9. doi: 10.2967/jnumed.112.115675.

2.

99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.

Broisat A, Toczek J, Dumas LS, Ahmadi M, Bacot S, Perret P, Slimani L, Barone-Rochette G, Soubies A, Devoogdt N, Lahoutte T, Fagret D, Riou LM, Ghezzi C.

J Nucl Med. 2014 Oct;55(10):1678-84. doi: 10.2967/jnumed.114.143792.

3.

Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p.

Broisat A, Riou LM, Ardisson V, Boturyn D, Dumy P, Fagret D, Ghezzi C.

Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):830-40.

PMID:
17219135
4.

Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

De Vos J, Mathijs I, Xavier C, Massa S, Wernery U, Bouwens L, Lahoutte T, Muyldermans S, Devoogdt N.

Mol Imaging Biol. 2014 Oct;16(5):690-8. doi: 10.1007/s11307-014-0731-6.

PMID:
24687730
5.

In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Glaudemans AW, Bonanno E, Galli F, Zeebregts CJ, de Vries EF, Koole M, Luurtsema G, Boersma HH, Taurino M, Slart RH, Signore A.

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1710-9. doi: 10.1007/s00259-014-2764-0.

PMID:
24737117
6.

Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand.

Liu Z, Lerman LO, Tang H, Barber C, Wan L, Hui MM, Furenlid LR, Woolfenden JM.

Nucl Med Biol. 2014 Nov-Dec;41(10):785-92. doi: 10.1016/j.nucmedbio.2014.08.004.

8.

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.

Broisat A, Hernot S, Toczek J, De Vos J, Riou LM, Martin S, Ahmadi M, Thielens N, Wernery U, Caveliers V, Muyldermans S, Lahoutte T, Fagret D, Ghezzi C, Devoogdt N.

Circ Res. 2012 Mar 30;110(7):927-37. doi: 10.1161/CIRCRESAHA.112.265140.

9.

Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.

Dietrich T, Berndorff D, Heinrich T, Hucko T, Stepina E, Hauff P, Dinkelborg LM, Atrott K, Giovannoni L, Neri D, Fleck E, Graf K, Menssen HD.

Q J Nucl Med Mol Imaging. 2015 Jun;59(2):228-37.

PMID:
25864530
10.

Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque.

Pan X, Hou R, Ma A, Wang T, Wu M, Zhu X, Yang S, Xiao X.

Cell Mol Neurobiol. 2017 Jan;37(1):29-36. doi: 10.1007/s10571-016-0331-x.

PMID:
26886754
11.

64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.

Jiang L, Tu Y, Kimura RH, Habte F, Chen H, Cheng K, Shi H, Gambhir SS, Cheng Z.

J Nucl Med. 2015 Jun;56(6):939-44. doi: 10.2967/jnumed.115.155176.

12.

Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging.

Ogawa M, Umeda IO, Kosugi M, Kawai A, Hamaya Y, Takashima M, Yin H, Kudoh T, Seno M, Magata Y.

J Nucl Med. 2014 Jan;55(1):115-20. doi: 10.2967/jnumed.113.123158.

13.

SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.

Liu C, Zhang X, Song Y, Wang Y, Zhang F, Zhang Y, Zhang Y, Lan X.

Atherosclerosis. 2016 Nov;254:263-270. doi: 10.1016/j.atherosclerosis.2016.09.005.

PMID:
27680307
14.

In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging.

De Saint-Hubert M, Bauwens M, Deckers N, Drummen M, Douma K, Granton P, Hendrikx G, Kusters D, Bucerius J, Reutelingsperger CP, Mottaghy FM.

Mol Imaging Biol. 2014 Apr;16(2):246-54. doi: 10.1007/s11307-013-0677-0.

PMID:
23979833
15.

Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque.

Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H.

J Nucl Med. 2008 Oct;49(10):1677-85. doi: 10.2967/jnumed.107.049536.

16.

Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.

Chan JM, Monaco C, Wylezinska-Arridge M, Tremoleda JL, Gibbs RG.

Eur J Vasc Endovasc Surg. 2014 May;47(5):462-9. doi: 10.1016/j.ejvs.2014.01.017.

17.

Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.

Zhao Y, Watanabe A, Zhao S, Kobayashi T, Fukao K, Tanaka Y, Nakano T, Yoshida T, Takemoto H, Tamaki N, Kuge Y.

PLoS One. 2014 Feb 19;9(2):e89338. doi: 10.1371/journal.pone.0089338.

18.

18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1213-22. doi: 10.1016/j.jcmg.2009.04.016.

19.

Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.

Ayala-López W, Xia W, Varghese B, Low PS.

J Nucl Med. 2010 May;51(5):768-74. doi: 10.2967/jnumed.109.071324.

20.

Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients.

Opalinska M, Stompor T, Pach D, Mikolajczak R, Fedak D, Krzanowski M, Rakowski T, Sowa-Staszczak A, Glowa B, Garnuszek P, Maurin M, Karczmarczyk U, Sulowicz W, Hubalewska-Dydejczyk A.

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):673-82. doi: 10.1007/s00259-011-2026-3.

Supplemental Content

Support Center